Moxifix Injection 400 mg/250 ml contains Moxifloxacin Hydrochloride, a broad-spectrum fluoroquinolone antibiotic formulated for intravenous administration. It is indicated for the treatment of serious bacterial infections where parenteral therapy is required or when oral administration is not feasible. With its potent antibacterial activity and once-daily dosing regimen, Moxifix Injection provides effective and reliable infection control in hospitalized or critically ill patients.

Moxifloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. By disrupting these processes, the drug prevents bacterial multiplication and promotes rapid bacterial cell death. Its extended spectrum of activity includes Gram-positive bacteria, Gram-negative bacteria, and atypical pathogens, making it especially useful in respiratory and intra-abdominal infections.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Moxifix Injection 400 mg/250 ml is indicated for the treatment of infections caused by susceptible organisms, including:

• Community-acquired pneumonia

• Complicated skin and soft tissue infections

• Complicated intra-abdominal infections

• Acute bacterial sinusitis (in severe cases requiring IV therapy)

• Acute exacerbation of chronic bronchitis (when appropriate)

It should be used based on clinical judgment and, whenever possible, supported by culture and sensitivity data.

Dosage and Administration

The recommended adult dose is 400 mg administered once daily by intravenous infusion. The infusion should be given over at least 60 minutes to minimize potential adverse reactions.

The duration of therapy depends on the severity and type of infection and should be determined by the treating physician. Patients may be switched from intravenous to oral moxifloxacin therapy once clinical improvement is observed.

No dosage adjustment is generally required for patients with mild to moderate renal impairment. However, caution is advised in patients with severe hepatic dysfunction.

Precautions and Warnings

• Fluoroquinolones may increase the risk of tendonitis and tendon rupture, particularly in elderly patients and those on corticosteroid therapy.

• Moxifloxacin can prolong the QT interval; use cautiously in patients with known cardiac conditions or those taking other QT-prolonging medications.

• May cause central nervous system effects such as dizziness, confusion, or seizures.

• Not recommended during pregnancy and breastfeeding unless clearly necessary.

• Avoid use in pediatric patients unless specifically advised by a healthcare professional.

Careful monitoring is recommended in patients with underlying medical conditions.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects may include:

• Nausea and vomiting

• Diarrhea

• Headache

• Dizziness

• Injection site reactions

Rare but serious adverse effects such as severe hypersensitivity reactions, cardiac arrhythmias, tendon rupture, or severe skin reactions may occur. Immediate medical attention is required if severe reactions develop.

Storage

Store below 30°C, protected from light. Do not freeze. Keep out of reach of children.

Moxifix Injection 400 mg/250 ml provides effective intravenous antibiotic therapy for serious bacterial infections, ensuring dependable treatment outcomes under proper medical supervision.